Aida Pharmaceuticals, Inc. Company Review & Valuation

AIDA
OTC Markets
Latest Price
0.00USD

About Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China.

It offers antibiotics, cardiovascular, and anti-cancer drugs.

The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.

The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers.

Aida Pharmaceuticals, Inc.

was founded in 1999 and is headquartered in Hangzhou, China.

Industry
Business Services
HQ Location
Hangzhou, China

Stock Price

Price data not available for Aida Pharmaceuticals, Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl